A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population

References

• Rugge M. Secondary prevention of gastric cancer. Gut 2007;56:1646–7.
   PubMedGoogle Scholar
• Agreus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136–47.
   PubMed Web of Science ®Google Scholar
• Farias CB, Lima RC, Lima LO, Flores DG, Meurer L, Brunetto AL, et al. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling. Oncology 2008;75:27–31.
   PubMedGoogle Scholar
• Sawada M, Dickinson CJ. The G cell. Annu Rev Physiol 1997;59:273–98.
   PubMedGoogle Scholar
• Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 2001;63:119–39.
   PubMed Web of Science ®Google Scholar
• Hallissey MT, Dunn JA, Fielding JW. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scand J Gastroenterol 1994;29:1129–34.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37:785–91.
   PubMed Web of Science ®Google Scholar
• Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004;99:1910–15.
   PubMedGoogle Scholar
• Benberin V, Bektayeva R, Karabayeva R, Lebedev A, Akemeyeva K, Paloheimo L, et al. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers. Anticancer Res 2013;33:4595–602.
   PubMed Web of Science ®Google Scholar
• Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, et al. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scand J Gastroenterol 2014;3:259–66.
   Google Scholar
• Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, et al. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer 2014; Epub ahead of print.
   PubMedGoogle Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–81.
   PubMed Web of Science ®Google Scholar
• Guariso G, Basso D, Bortoluzzi CF, Meneghel A, Schiavon S, Fogar P, et al. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. Clin Chim Acta 2009;402:54–60.
   PubMedGoogle Scholar
• Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008;6:174–9.
   PubMed Web of Science ®Google Scholar
• Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, et al. Value of gastrin-17 in detecting antral atrophy. Adv Med Sci 2011;56:145–50.
   PubMedGoogle Scholar
• Song DH, Rana B, Wolfe JR, Crimmins G, Choi C, Albanese C, et al. Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am J Physiol Gastrointest Liver Physiol 2003;285:G217–22.
   Google Scholar
• Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer 2006;6:936–46.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Fossmark R, Bakke I, Martinsen TC, Qvigstad G. Hypergastrinemia in animals and man: causes and consequences. Scand J Gastroenterol 2004;39:505–9.
   PubMed Web of Science ®Google Scholar
• Fossmark R, Qvigstad G, Martinsen TC, Hauso O, Waldum HL. Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis. J Biomed Biotechnol 2011;2011:1–6.
   Google Scholar
• Waldum HL, Hauso O, Fossmark R. The regulation of gastric acid secretion - clinical perspectives. Acta Physiol (Oxf) 2013;210:239–56.
   PubMedGoogle Scholar
• Tanaka I, Tatsumi Y, Kodama T, Kato K, Fujita S, Mitsufuji S, et al. Effect of Helicobacter pylori eradication on gastroesophageal function. J Gastroenterol Hepatol 2004;19:251–7.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Sun L, Gong YH, Wang XG, Zhang M, Yuan Y. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese. J Dig Dis 2007;8:72–6.
   PubMedGoogle Scholar
• Nie XR, Zhou T, Pan KF, Li WQ, Feng GS, Zhang Y, et al. [The associations of serum gastrin level with Helicobacter pylori infection]. Zhonghua Yu Fang Yi Xue Za Zhi 2007;41(Suppl):87–9.
   PubMedGoogle Scholar
• Kato S, Ozawa K, Koike T, Sekine H, Ohara S, Minoura T, et al. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children. Helicobacter 2004;9:100–5.
   PubMedGoogle Scholar
• Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. J Gastroenterol Hepatol 2008;23:1666–71.
   PubMedGoogle Scholar
• Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007;8:15–22.
   Google Scholar
• Derakhshan MH, El-Omar E, Oien K, Gillen D, Fyfe V, Crabtree JE, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 2006;59:1293–9.
   PubMedGoogle Scholar
• Wong D, Ogle CW. The contrasting influence of chronic nicotine intake on gastrin and gastric acid secretion. J Gastroenterol Hepatol 1995;10:577–84.
   PubMedGoogle Scholar
• Gomez G, Lambertz I, Udupi V, Qi X, Thompson JC, Greeley GH Jr. Influence of nicotine on gastrin and peptide YY in the rat. Regul Pept 1996;67:55–61.
   PubMedGoogle Scholar
• Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, et al. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One 2011;6:e26957.
   PubMed Web of Science ®Google Scholar
• di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis 2008;40:523–30.
   PubMedGoogle Scholar
• Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006;12:7172–8.
   PubMedGoogle Scholar
• Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2–10.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772–81.
   PubMed Web of Science ®Google Scholar
• Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci 2009;54:2377–84.
   PubMed Web of Science ®Google Scholar
• Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol 2012;12:10.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Kumar S, Krishnani N, Kumari N, Chourasia D, Tripathi S. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection. Trop Gastroenterol 2011;32:292–8.
   PubMedGoogle Scholar